InvestorsHub Logo
Post# of 64577
Next 10
Followers 13
Posts 121
Boards Moderated 0
Alias Born 04/20/2018

Re: None

Tuesday, 03/19/2019 3:12:27 AM

Tuesday, March 19, 2019 3:12:27 AM

Post# of 64577
$ATOS late news yesterday.. 10 million from exercises outstanding warrants. Partnerships tend to be common for clinical stage biotechs. Cash up front, milestones, reimbursement for R&D typical. Pathway to monetize drug. Continuation continues imo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.